Tag: Robert Flello

The below Parliamentary question was asked by Robert Flello on 2015-01-15.

To ask the Secretary of State for Transport, if he will commission trials of the Siemens eHighway in the UK similar to those conducted in California.

Mr John Hayes

The Highways Agency is currently investigating the feasibility of inductive wireless power transfer technology that meets the needs of all vehicles. This is in alignment with the work defined as part of the Innovation funding in the Roads Investment Strategy. There are currently no plans to trial other technologies.

The below Parliamentary question was asked by Robert Flello on 2015-02-10.

To ask the Secretary of State for Health, with reference to Part 5 (a) (ii) of the Mitochndrial Donation Regulations 2015, how the Human Fertilisation and Embryology Authority plans to define a significant risk” of having or developing serious mitochondrial disease.”

Jane Ellison

The Human Fertilisation and Embryology Authority has advised that if Parliament passes the Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015, it will need to design a regulatory process of which the consideration of “significant risk” is a part. In designing that process it will take into account, where relevant, the existing regulatory process for embryo testing (preimplantation genetic diagnosis).

The below Parliamentary question was asked by Robert Flello on 2015-02-10.

To ask the Secretary of State for Health, if he will make it his policy to require the Human Fertilisation and Embryology Authority to produce further regular scientific reviews of the evidence concerning the safety and effectiveness of mitochondrial donation.

Jane Ellison

The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 require the Human Fertilisation and Embryology Authority to assess each application for mitochondrial donation on a case-by-case basis. This will include consideration of the evidence of safety and effectiveness.

The below Parliamentary question was asked by Robert Flello on 2015-02-10.

To ask the Secretary of State for Health, if he will make it his policy to review the Mitochondrial Donation Regulations 2015 in the event that (a) research by Dr Shoukhrat Mitalipov at Oregon Health and Science University and (b) other research in non-human primates shows pro-nuclear transfer to be unsafe or ineffective.

Jane Ellison

The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations 2015 require the Human Fertilisation and Embryology Authority to assess each application for mitochondrial donation on a case-by-case basis. This will include consideration of the evidence of safety and effectiveness.

The below Parliamentary question was asked by Robert Flello on 2014-06-25.

To ask the Secretary of State for Health, how many adults with autism in England receive support under the current social care system; and how many such adults will receive support under the system proposed in the Care Act 2014 Part 1 regulations.

Norman Lamb

The Care Act 2014 will reform the care and support system for everyone, including adults with autism. The core principles of the Care Act 2014 and the regulations and statutory guidance which support its implementation are to maintain the wellbeing of people who have care and support needs and support them in living independent lives.

The draft regulations and guidance were co-produced with stakeholders, and this included engaging with the National Autistic Society. The Department is currently consulting on the regulations and statutory guidance that will support the implementation of the Care Act 2014. The public consultation started on 6 June and runs until 15 August 2014.

The Health and Social Care Information Centre does not collect any data on the number of adults with autism receiving support under the current, or proposed, social care systems and therefore are unable to provide a response. The national eligibility criteria being introduced under the Care Act 2014 will allow local authorities to maintain levels of access for service users when they move from the current framework to the new care and support system in April 2015.

The below Parliamentary question was asked by Robert Flello on 2015-02-20.

To ask the Secretary of State for Health, whether his Department has made an estimate of the change in the number of donor eggs that will be required by the authorisation of mitochondrial donation.

Jane Ellison

I refer the hon. Member to the answer I gave to the hon. Member for North Tyneside (Mrs Mary Glindon) to PQ 208397 on 11 September 2014.

“

The below Parliamentary question was asked by Robert Flello on 2014-06-25.

To ask the Secretary of State for Health, what assessment his Department has made of the effect of the proposed changes to the social care system in the Care Act 2014 Part 1 regulations on adults with autism.

Norman Lamb

The Care Act 2014 will reform the care and support system for everyone, including adults with autism. The core principles of the Care Act 2014 and the regulations and statutory guidance which support its implementation are to maintain the wellbeing of people who have care and support needs and support them in living independent lives.

The draft regulations and guidance were co-produced with stakeholders, and this included engaging with the National Autistic Society. The Department is currently consulting on the regulations and statutory guidance that will support the implementation of the Care Act 2014. The public consultation started on 6 June and runs until 15 August 2014.

The Health and Social Care Information Centre does not collect any data on the number of adults with autism receiving support under the current, or proposed, social care systems and therefore are unable to provide a response. The national eligibility criteria being introduced under the Care Act 2014 will allow local authorities to maintain levels of access for service users when they move from the current framework to the new care and support system in April 2015.

The below Parliamentary question was asked by Robert Flello on 2015-02-20.

To ask the Secretary of State for Health, pursuant to the Answer of 10 February 2015 to Question HL4441, whether the Human Fertilisation and Embryology Authority imposed sanctions on clinics that had administered reagents to permitted gametes or permitted embryos that are then introduced into patients when the reagents concerned had not been CE marked; and when the Medicines and Healthcare products Regulatory Agency was notified of such instances documented in inspection reports.

Jane Ellison

The Human Fertilisation and Embryology Authority has advised that it has not been necessary to impose any regulatory sanctions in relation to the use of non CE marked reagents or products, as the clinics in question have given a commitment, as part of the inspection process, to use alternative CE marked products. The Medicines and Healthcare products Regulatory Agency is not notified of individual instances as reported in inspection reports, as its responsibilities relate to the manufacturers of these products not the users.

The below Parliamentary question was asked by Robert Flello on 2014-06-24.

To ask the Secretary of State for Foreign and Commonwealth Affairs, if he will make representations to his Colombian counterpart to support the requests for an investigation into the death of Yonni Steven Caicedo, a television cameraman in Colombia shot dead on 19 February 2014.

Mr Hugo Swire

I met representatives from six human rights organisations, including Oxfam and Christian Aid as well as Colombian non-governmental organisations (NGOs) during my visit to Bogotá last week. I also met two Deputy Ministers for Foreign Affairs, heads of the Colombian Government’s major human rights agencies and representatives of the Attorney-General’s office. I set out HM Government concern about the reported rise in attacks against human rights defenders and a lack of sentences for those responsible.

The below Parliamentary question was asked by Robert Flello on 2015-02-12.

To ask the Secretary of State for Environment, Food and Rural Affairs, what analysis and research her Department has undertaken into the potential risk to human health of the transportation of animal carcasses and animal products in unsealed and unrefrigerated vehicles to rendering facilities.

George Eustice

Defra has not undertaken research into the potential risk to human health of the transportation of animal carcasses and animal products in unsealed and unrefrigerated vehicles to rendering facilities.

EU animal by-products (ABP) legislation, which is in force to protect public and animal health, requires animal carcasses and other ABP material to be collected and transported in sealed new packaging or covered leak-proof containers or vehicles at an appropriate temperature. Non-compliance with this requirement is a criminal offence under the Animal By-Products (Enforcement) (England) Regulations 2013. In addition, the Government has been urging the rendering industry to consider what improvements can be made to current practice when transporting ABPs and on the issue of cooling carcasse material.

The Department understands that the rendering industry is currently undertaking and funding its own research into the costs and benefits of chilling ABPs during storage and transport.